Zydus Cadila receives USFDA approval to market its anti-diabetic drug
Zydus Cadila has got the tentative approval from the US health regulator for marketing anti-diabetic sitagliptin and metformin hydrochloride in the US market. Cadila Healthcare...
Download Unicorn Signals App
Powered By EquityPandit
